WEBINAR SERIES
Unlocking strategic value in Drug Safety for Life Sciences organizations
This webinar aims to explore the transformation of safety teams from reactive cost centers to proactive benefit drivers, emphasizing the importance of providing teams with the right tools & resources to gain actionable insights.
- Vigilance
- 1 Hour
- English
Main Topics
We will discuss the key elements for life sciences organizations to unlock strategic value in safety, including:
Regulatory Compliance and Updates
Latest regulations (EU / LATAM) and compliance requirements in drug safety to navigate the complex regulatory landscape.
Technology Integration for Pharmacovigilance
Latest advancements in technology, artificial intelligence and data analytics to enhance pharmacovigilance capabilities and streamline safety monitoring processes.
Global Collaboration in Safety Monitoring
International collaboration in drug safety, best practices for global pharmacovigilance and strategies for harmonizing safety reporting across different regions.
Patient-Centric Approaches to Pharmacovigilance through Digital Health Technologies
Highlighting digital health’s impact on patient empowerment, adherence, and real-time data for improved pharmacovigilance and adverse event reporting.
Leveraging Real-World Data for Enhanced Drug Safety
Exploring RWD’s role in safety signal identification and decision-making for personalized, safer patient outcomes in pharmacovigilance.
Speaker
Dr. Ángel Navarro
Dr. Angel Navarro is the Country Manager of Spain of QbD Group and Head of Vigilance Division. Founder and CEO of Azierta for more than 12 years (Azierta part of QbD Group), his track record endorses him as a strategic leader in the international pharmaceutical sector.
Speaker
Dr. Antonio Borregón
Dr. Antonio Borregón is the Global Business Development Pharma Head at QbD. He has extensive experience in the pharmaceutical field with high-responsibility positions at the international level.
Speaker
Dr. Richard Habis
Richard Habis, a PharmD graduate from Saint Joseph University of Beirut, is a seasoned expert in biopharmaceutical consulting and market research. With a keen focus on rare diseases and patient-centered care, his expertise extends to leveraging real-world data to drive patient outcomes and healthcare insights. Mr. Habis’s professional journey reflects a strong commitment to integrating patient perspectives in digital health solutions.